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Covalent attachment of anti-rat erythrocyte F(ab’), to liposomes specifically enhanced their binding to rat 
erythrocytes in vivo and reduced their uptake by the liver. Furthermore, at least 20-30s of the cell-bound 
liposomes delivered their contents to the cells. Besides, the liposome binding did not affect the survival time 
of the target cells at least up to 3 h in the blood circulation. These results demonstrate for the first time 
that liposomes can be successfully targeted to cells other than liver cells in vivo. 
Drug targeting Liposome Cell-spec$c antibody F(ab’)z fragment (Erythrocyte) 
1. INTRODUCTION 2.1. Anti-rat erythrocyte F(ab 7.2 
Liposomes coated with cell-specific ligands may 
prove highly useful as carriers for site-specific 
delivery of drugs and enzymes in the biophase 
[ 1,2]. Several studies have been carried out on the 
interactions of such liposomes with specific cells in 
vitro [3-91, but only few attempts have been made 
to examine the suitability of this method for 
drug/enzyme delivery to the selected cells in vivo 
[ 10-121. Here, we describe the results of our 
studies on targeting of liposomes to rat red cells in 
vivo. 
Anti-rat erythrocyte F(ab’)z were prepared and 
purified as in [9]. Radiolabelling of the antibody 
was carried out according to [ 141. 
2.2. Liposomes 
Liposomes were prepared from egg PC 
(20 pmol), cholesterol (20 pmol), gangliosides 
(4 ,umol) and traces of egg [14C]PC (about 20 pCi) 
or [‘4C]sucrose (about 250&i) or [3H]inulin 
(about 500&i) in 0.8 ml borate-buffered saline 
(10 mM borate containing 60 mM NaCI, pH 8.4) 
by sonication [ 151, and fractionated by centrifuga- 
tion [7]. Free [14C]sucrose (or t3H]inulin) from the 
liposomised sucrose (or inulin) was removed by gel 
filtration over Sephadex G-50 as in [ 131. The mean 
outer diameter of these liposomes, as determined 
by molecular sieve column chromatography [151, 
was about 45 nm. 
2. MATERIALS AND METHODS 
Na12’I (carrier-free), sodium [51Cr]chromate 
and [14C]sucrose were obtained from Bhabha 
Atomic Research Centre, Trombay, India. [3H]In- 
ulin was from Amersham, England. Egg [14C]PC 
was prepared as in [13]. 
* To whom correspondence should be addressed 
Abbreviation: PC, phosphatidylcholine 
2.3. Anti-rat erythrocyte F(ab 72 bearing 
liposomes 
‘251-labelled (or unlabelled) anti-rat erythrocyte 
F(ab’)z were covalently attached to liposomes as in 
[9]. The protein-to-lipid ratio in the liposomes was 
about 70-lOO pug protein/pmol lipid P. 
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2.4. Fab ’ fragments of anti-anti-rat erythrocyte 
F(ab ‘)z antibody 
Anti-anti-rat erythrocyte F(ab’)z antibody was 
raised in sheep, and isolated from antiserum by the 
ammonium sulphate precipitation method [ 161. 
Fab’ fragments of this antibody were prepared 
essentially as in [ 171. 
2.5. Tissue distribution of liposomes 
Liposomes (0.8-l .2 pmol lipid P, 400 ~1) were 
injected into the tail vein of male albino rats 
(Charles Foster; average weight about 100 g). 
Blood (about 20~1) was drawn immediately 
(<2 min) after injecting the liposomes, by retro- 
orbital puncture in heparinized capillary pipettes, 
and transferred to preweighed scintillation vials. 
The vials were reweighed and counted for radioac- 
tivity [9]. The 14C and 3H counts were corrected 
for quenching by haemoglobin. Total radioactivity 
injected in each animal was calculated from the 
2 min value by assuming total blood volume as 8% 
of the body weight. The egg PC-cholesterol- 
ganglioside liposomes that were not coupled to 
anti-erythrocyte F(ab’)a were used as controls 
throughout this study. For determining the tissue 
distribution of liposomes in vivo, the animals were 
killed immediately after drawing about 2 ml blood 
at 15 min after the injection, and the various 
organs (liver, spleen, lung, kidney and heart) 
removed, washed, blotted and weighed. A 10% 
(w/v) homogenate of these organs was prepared in 
sucrose-supplemented Tris-buffered saline (10 mM 
Tris containing 150 mM NaCl, 44 mM sucrose and 
5 mM EDTA, pH 7.4). A measured aliquot of 
each homogenate was analysed for radioactivity. 
Distribution of radioactivity in blood was deter- 
mined as follows: the blood (1 ml) drawn at 
15 min was centrifuged. Plasma was carefully 
aspirated off and transferred to a glass tube. A 
fixed aliquot of plasma was analysed for radioac- 
tivity. The cell pellet remaining after plasma 
removal was diluted to 50% haematocrit with 
sucrose-supplemented Tris-buffered saline, and 
the erythrocytes separated from the white blood 
cells by using a Ficoll-Conray gradient [9]. The 
white and red blood cells were washed, and 
separately suspended in buffer. A measured ali- 
quot containing a known number of cells was 
analysed for radioactivity. The total amount of 
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radioactivity associated with red cells and plasma 
in vivo was calculated by determining the number 
of red cells/ml blood (6.2 +- 0.5 x lo9 cells; 10 
animals) and the packed cell volume/100 ml blood 
(38 k 2 ml; 10 animals), respectively. The total 
blood volume was assumed as 8% of the body 
weight. Both 12’1 and r4C (or ‘H) counts in the 
total leukocyte pellet were close to the background 
levels (about 3 x 10-4% and 2 x 10-5% of the in- 
jected dose of 12jI and 14C, respectively), and 
hence the amount of leukocyte-associated 
liposomes could not be determined accurately. 
2.6. “Cr-labeled liposome-bound erythrocytes 
Liposomes (2 pmol lipid P) containing egg 
[14C]PC were incubated with rat erythrocytes 
(about 5 x lo9 cells) in buffer (1 ml) at 37°C for 
15 min. The cells were harvested by centrifugation, 
and washed several times till no radioactivity was 
detected in the washings. The amounts of red cell- 
associated anti-rat erythrocyte F(ab’)z bearing 
liposomes and control liposomes were about 
6%/109 cells and 0.2%/109 cells, respectively. 
These liposome-bound cells were labelled with “Cr 
according to [18]. In identical conditions, fresh red 
cells isolated from rat blood were also labelled with 
“Cr. 
2.7. Liposome-bound erythrocyte’s survival in 
blood circulation 
51Cr-labelled liposome-untreated, control 
liposome-treated and antibody bearing liposome- 
treated erythrocytes (about 5 x 10’ cells/animal) 
were separately administered intravenously to rats 
(average weight 100 g). The total amount of 
radioactivity injected in each animal was 
calculated from a 2 min post-injection blood sam- 
ple, as described above. The amount of radioac- 
tivity remaining in blood at various periods of time 
was determined as follows: blood (about 20 ~1) was 
drawn in heparinized capillary pipettes, and 
transferred to preweighed scintillation vials. The 
vials were reweighed and counted for radioactivity. 
The 14C counts were corrected for quenching by 
haemoglobin. At 3 h after the injection, the 
animals were killed, and the various organs were 
taken out and processed as described in section 
2.4. 
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3. RESULTS AND DISCUSSION 
Unilamellar liposomes were prepared from egg 
PC, cholesterol and gangliosides by sonication, 
and fractionated by centrifugation, as described in 
section 2. These liposomes were covalently coupled 
to 1251-labelled anti-rat erythrocyte F(ab’)z, and 
their tissue distribution determined in rats. The 
liposomes that were not attached to the antibody, 
rather than normal rabbit IgG F(ab’)z bearing 
liposomes [9], were used as controls throughout 
this study. These liposomes were selected since the 
use of rabbit IgG F(ab’)z bearing liposomes as 
controls would not allow us to determine the ef- 
fect, if any, of the protein coupling on the blood 
clearance rate of antibody bearing liposomes from 
the circulation [12]. 
Fig. 1 shows that tissue distribution of liposomes 
is significantly modified upon attaching anti-rat 
erythrocyte F(ab’)z to their surface. A con- 
siderably larger (12- 19070) proportion of liposomes 
became associated with the erythrocytes whereas 
there was an appreciable decrease in the amounts 
of liposomes that localized in liver, spleen and 
plasma. However, only negligible amounts 
(~0.005%) of liposomes were found to be 
associated with the white blood cells, and these 
amounts did not increase by coupling the 
liposomes to the antibody. Besides, similar frac- 
tions of antibody bearing liposomal 14C (or ‘H) 
and “‘1 were associated with the various tissues 
(fig.l), indicating that the structural integrity of 
these liposomes was not greatly affected in blood 
circulation [ 191. These findings demonstrate that 
covalent attachment of anti-rat erythrocyte F(ab’)z 
to the liposomes specifically enhances their binding 
to rat erythrocytes in vivo, and reduces their up- 
take by the liver and spleen. 
To ascertain whether the liposome binding to 
red cells is time-dependent, we measured the 
amount of red cell-bound radioactivity at various 
periods of time after injecting liposomes in rats. 
Fig.2A shows that the liposome binding to these 
cells does not increase with time, and that the ex- 
tent of this binding at 3 h is identical to that 
observed at 15 min. This demonstrates that the 
binding between erythrocytes and liposomes is a 
very fast process, which is consistent with the 
earlier studies [3,4,9]. However, the liposomal 
radioactivity in plasma decreased with time 
70 
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Fig.1. Distribution of liposomes in various 
organs/tissues. Values shown are mean of 4-6 
animals f SD. (A) Liposomes containing egg [‘4C]PC, 
before (t4C, open bars) and after coupling to “‘I- 
labelled anti-rat erythrocyte F(ab’)z (14C, solid bars; 
125 
1, shaded bars). (B) Liposomes containing 
]14C]sucrose, before (14C, open bars) and after coupling 
to ‘*‘I-labelled anti-rat erythrocyte F(ab’)s (14C, solid 
bars; ‘*? shaded bars). (C) Liposomes containing 
[3H]inulin: before (3H, open bars) and after coupling to 
‘2SI-labelled anti-rat erythrocyte F(ab’)z (3H, solid bars; 
‘*‘I, shaded bars). RBC, red blood cells. 
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Fig.2. Liposomes containing egg [‘4C]PC were injected 
in rats (average weight 220 g) and the amount of 
radioactivity associated with erythrocytes (A) and the 
remaining radioactivity in plasma (B) at various periods 
of time determined, before (open circie, Iiposomal 14C) 
and after coupling them to ‘2SI-labelIed anti-rat 
erythrocyte F(ab’)z (solid circles, liposomal 14C; solid 
triangles, liposomal lz51), as in fig. 1, except that 300 ~1 
blood was drawn at each time point. Values shown are 
mean of 6 animals + SD. 
(fig.2B). This decrease in case of the control 
liposomes was faster than that observed for the an- 
tibody bearing liposomes, suggesting that the 
blood clearance rate of the liposomes is reduced by 
coupling them to the antibody. This is quite consis- 
tent with our finding that the difference between 
the liver-associated amounts of control and an- 
tibody bearing liposomes was greater at 3 h (fig.3), 
as compared to that at 15 min (fig.lA). 
Further experiments were done to investigate the 
effects of the injected dose of liposomes on the ex- 
tent of their binding to the target cells, and also on 
their distribution patterns in the various organs. 
Both the extent of liposome binding to 
Fig.3. Distribution of egg [14C]PC containing liposomes 
in various organs at 3 h after the injection, before (open 
bars, ‘*C) and after coupling them to 12s1-labelled anti- 
rat erythrocyte F(ab’)z (solid bars, 14C; shaded bars, 
“‘1). Values shown are mean of 6 animals k SD. 
erythrocytes and the organ distribution patterns re- 
mained unchanged by varying the injected dose 
between 0.6 and 2ymol lipid P/animal (not 
shown). 
Since delivery of the liposomised solutes to the 
target cells will be ensured only if the cell-bound 
liposomes either fuse with the cell membrane or 
become internalised via endocytosis 1201, we 
analysed the mode of interaction between 
erythrocytes and antibody bearing liposomes in the 
liposome-bound cells obtained from the 15 min 
blood samples of the injected animals. Firstly, we 
estimated the amounts of liposomes that were ad- 
sorbed on the cell surface. The surface-adsorbed 
liposomes were eiuted by washing (5-7 times) the 
liposome-bound cells (0.2-0.3 ml packed volume) 
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with a solution (7 mg protein/ml, 3 ml each time) 
of Fab’ fragments of anti-anti-rat erythrocyte 
F(ab’)z antibody. Only 25-30070 of the cell-bound 
liposomes could be eluted by this method. The 
maximum amount of liposomes was eluted in the 
first and second washings whereas the last washing 
was completely free of radioactivity. Secondly, we 
attempted to measure the amount of free 
[14C]sucrose (or [3H]inulin) delivered to the cells 
by the liposomes, as it should allow us to ascertain 
the degree to which liposomes fuse with the cells 
[20]. The Fab ’ -washed cells (about 0.2 ml packed 
volume) were transferred to a 3 ml centrifuge tube, 
and lysed at 0°C by adding 9 vols precooled dis- 
tilled water. It was centrifuged at 25000 x g for 
30 min at 4°C. The supernatant was carefully 
transferred to a glass tube. The pellet was washed 
with water (2 ml), and the washing was mixed with 
the first supernatant. The washed pellet was 
diluted with an equal volume of water and 
measured aliquots of both the supernatant and the 
pellet were analysed for radioactivity. The 
liposomal membrane radioactive markers (viz. 
‘2’I-labelled F(ab’)z and egg [14C]PC) were ex- 
clusively (>98%) associated with the cell pellet 
whereas a considerable proportion (23-38%) of 
the entrapped markers (viz. [14C]sucrose and 
[3H]inulin) was also present in the supernatant. 
These amounts of the liposomal solutes in the 
cytosol were not due to leakage of the entrapped 
solutes from the cell-bound liposomes, as lOO-fold 
dilution with distilled water was found not to in- 
duce any leakage (< 1%) from the liposomes that 
were not bound to the cells. Moreover, no 
[14C]sucrose (or [3H]inulin) could be detected in 
the supernatant even upon overnight storage of the 
Fab ’ -washed liposome-bound cells in buffer at 
4°C. From these findings, we infer that of the 
erythrocyte-bound liposomes, at least 25-30070 in- 
teract with the cells via adsorption, 20-30070 prob- 
ably via membrane-membrane fusion, and the 
rest may have interacted with the cells via some 
other mechanisms [20,21]. 
Interactions of red cells with liposomes are 
known to alter their membrane deformability [22], 
which in turn could accelerate their destruction by 
the spleen [23]. Therefore, to examine whether the 
liposome binding has influenced the survival times 
of erythrocytes in the circulation, we measured the 
“Cr levels in the circulation after injecting 51Cr- 
labelled liposome-bound erythrocytes in rats, as 
described in section 2. The normal rat erythrocytes 
which did not receive any treatment with liposomes 
were used as controls in these experiments. Fig.4 
shows that the amounts of the control liposome- 
and antibody bearing liposome-treated cells in the 
circulation are similar to that of the control cells. 
Also, the fractions of the liposome-treated cells 
associated with the various organs (fig.5) were 
almost identical to those of the liposome untreated 
erythrocytes. These results strongly indicate that 
the interaction of the red cells with liposomes does 
not alter their stability or survival time at least up 
to 3 h in the circulation. Further, it may be noted 
50 L, 1 I . 1 I ,5O 
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Fig.4. Survival of liposome-treated red cells in 
circulation of rats. (A) Cells not treated with liposomes 
(solid circles, 5’Cr); (B) cells treated with egg [‘4C]PC- 
containing control liposomes (solid circles, “Cr; open 
circles, 14C); (C) cells treated with anti-rat erythrocyte 
F(ab’)z bearing liposomes containing egg [14C]PC (solid 
circles, “Cr; open circles, 14C). Values are mean of 4 
animals f SD. 
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Fig.5. Distribution of radioactivity in various organs at 
3 h after injecting “Cr-labelled liposome-treated (or 
untreated) red cells in rats. (A) Cells not treated with 
liposomes (open bars, “Cr); (B) cells treated with egg 
[‘4C]PC-containing control iposomes (open bars, “Cr; 
shaded bars, 14C); (C) cells treated with anti-rat 
erythrocyte F(ab’ )z bearing liposomes containing egg 
[14C]PC (open bars, “Cr; shaded bars, 14C). Values are 
mean of 4 animals f SD. 
in fig.4 that about 20% of the control liposomal 
14C and about 10% of the antibody bearing 
liposomal 14C disappeared from the circulation. 
These fractions may represent those liposomes 
which were loosely bound to the cells, and readily 
eluted from the cell surface by the plasma proteins 
in blood circulation. 
This study clearly shows that covalent attach- 
ment of cell-specific antibody to liposomes 
specifically enhances their binding to the target 
cells in vivo. Also, it demonstrates that a signifi- 
cant fraction of the cell-bound liposomes can 
deliver their contents even to an inert cell like the 
erythrocyte. We, therefore, conclude that 
liposomes coupled to cell-specific antibody may 
prove quite suitable for drug/enzyme delivery to 
specific cells in the biophase. 
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